Neurocrine Biosciences to Present at the SVB Securities Global Biopharma Conference

SAN DIEGO, Feb. 7, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the virtual SVB Securities Global Biopharma Conference at 12:00 p.m. Eastern Time on Tuesday, February 14, 2023. Kevin Gorman, Chief Executive Officer, and Matt Abernethy, Chief Financial…

Click here to view original post